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Intermediate progenitors in adult hippocampal neurogenesis:
Tbr2 expression and coordinate regulation of neuronal output
Abstract
Neurogenesis in the adult hippocampus is a highly regulated process that originates from multipotent
progenitors in the subgranular zone (SGZ). Currently, little is known about molecular mechanisms that
regulate proliferation and differentiation in the SGZ. To study the role of transcription factors (TFs), we
focused on Tbr2 (T-box brain gene 2), which has been implicated previously in developmental
glutamatergic neurogenesis. In adult mouse hippocampus, Tbr2 protein and Tbr2-GFP (green
fluorescent protein) transgene expression were specifically localized to intermediate-stage progenitor
cells (IPCs), a type of transit amplifying cells. The Tbr2+ IPCs were highly responsive to neurogenic
stimuli, more than doubling after voluntary wheel running. Notably, the Tbr2+ IPCs formed cellular
clusters, the average size of which (Tbr2+ cells per cluster) likewise more than doubled in runners.
Conversely, Tbr2+ IPCs were selectively depleted by antimitotic drugs, known to suppress
neurogenesis. After cessation of antimitotic treatment, recovery of neurogenesis was paralleled by
recovery of Tbr2+ IPCs, including a transient rebound above baseline numbers. Finally, Tbr2 was
examined in the context of additional TFs that, together, define a TF cascade in embryonic neocortical
neurogenesis (Pax6 --> Ngn2 --> Tbr2 --> NeuroD --> Tbr1). Remarkably, the same TF cascade was
found to be linked to stages of neuronal lineage progression in adult SGZ. These results suggest that
Tbr2+ IPCs play a major role in the regulation of adult hippocampal neurogenesis, and that a similar
transcriptional program controls neurogenesis in adult SGZ as in embryonic cerebral cortex.
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Neurogenesis in the adult hippocampus is a highly regulated process that originates from multipotent progenitors in the subgranular
zone (SGZ). Currently, little is knownaboutmolecularmechanisms that regulateproliferationanddifferentiation in theSGZ.To study the
role of transcription factors (TFs), we focused on Tbr2 (T-box brain gene 2) , which has been implicated previously in developmental
glutamatergic neurogenesis. In adultmouse hippocampus, Tbr2 protein andTbr2-GFP (green fluorescent protein) transgene expression
were specifically localized to intermediate-stage progenitor cells (IPCs), a type of transit amplifying cells. The Tbr2 IPCs were highly
responsive to neurogenic stimuli, more than doubling after voluntary wheel running. Notably, the Tbr2 IPCs formed cellular clusters,
the average size of which (Tbr2 cells per cluster) likewise more than doubled in runners. Conversely, Tbr2 IPCs were selectively
depleted by antimitotic drugs, known to suppress neurogenesis. After cessation of antimitotic treatment, recovery of neurogenesis was
paralleled by recovery of Tbr2 IPCs, including a transient rebound above baseline numbers. Finally, Tbr2 was examined in the context
of additional TFs that, together, define a TF cascade in embryonic neocortical neurogenesis (Pax63Ngn23Tbr23NeuroD3Tbr1).
Remarkably, the sameTFcascadewas found tobe linked to stages of neuronal lineageprogression in adult SGZ.These results suggest that
Tbr2 IPCs play a major role in the regulation of adult hippocampal neurogenesis, and that a similar transcriptional program controls
neurogenesis in adult SGZ as in embryonic cerebral cortex.
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Introduction
Adult hippocampal neurogenesis is a constitutive but highly reg-
ulated process that occurs in a neurogenic niche, the subgranular
zone (SGZ) of the dentate gyrus (DG). Progenitors in the SGZ
produce glutamatergic neurons that populate the granule cell
layer (GCL) of the DG (Kempermann et al., 2004b). Primary
progenitor cells (type-1), characterized by GFAP and nestin ex-
pression, exhibit morphology typical of radial glia and divide
slowly to produce intermediate progenitor cells (IPCs), a type of
transit amplifying cell (Filippov et al., 2003; Kempermann et al.,
2004b; Steiner et al., 2004, 2006). Undifferentiated IPCs (type-2a
and type-2b) divide rapidly to produce neuronal committed IPCs
(type-3) and are responsive to stimuli that affect neuron produc-
tion in the DG (van Praag et al., 1999; Steiner et al., 2004; Jess-
berger et al., 2005; Encinas et al., 2006). Type-3 IPCs generate
immature neurons, and those neurons that survive through an
experience-dependent regulatory period integrate into the GCL
as mature granule cells within 1 month (Kempermann et al.,
2004b; Tashiro et al., 2007). The functional significance of adult
neurogenesis is currently not well understood. However, studies
have correlated DG neurogenesis with cognitive function, mem-
ory, neurodegenerative diseases, and depression (Kempermann
et al., 2004a; Emsley et al., 2005; Encinas et al., 2006; Ernst et al.,
2006).
Interestingly, neurogenesis in the adult brain recapitulates
some aspects of neurogenesis in the developing brain (Pleasure et
al., 2000; Espo´sito et al., 2005; Nacher et al., 2005; Song et al.,
2005; Hevner et al., 2006), suggesting that progenitor cells in the
embryonic and adult brain may share similar molecular pheno-
types. In the developing brain, transcription factor (TF) cascades
(sequential expression of multiple TFs) are involved in control-
ling progenitor proliferation and specifying neuron identity and
neurotransmitter fate (Arlotta et al., 2005; Wang and Harris,
2005; Hevner, 2006; Guillemot, 2007). However, the role of TFs
in adult neurogenesis, with a few exceptions (Shi et al., 2004;
Maekawa et al., 2005; Shen et al., 2006), remains primarily un-
known. To better understand the molecular mechanisms regulat-
ing neurogenesis in the DG, we focused on characterizing the
expression of Tbr2, a T-domain TF previously reported to act as
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part of a cascade regulating glutamatergic
neuron production during cortical devel-
opment (Englund et al., 2005). In this TF
cascade, Pax6 radial glia produce IPCs
that express Tbr2, which then divide to
produce NeuroD neuroblasts that dif-
ferentiate into Tbr1 cortical neurons
(Haubensak et al., 2004; Miyata et al.,
2004; Noctor et al., 2004; Englund et al.,
2005). Ngn2, a proneural TF shown to be
regulated by Pax6 in the embryonic cortex
(Heins et al., 2002; Scardigli et al., 2003),
precedes Tbr2 expression in this TF cas-
cade. The present experiments were de-
signed to determine whether aspects of
this TF cascade are conserved in the adult
DG and to examine the identity of Tbr2
cells in the SGZ. Experiments were also
conducted to assess the responses of
Tbr2 cells to neurogenic stimuli, with
the goal of understanding how Tbr2
IPCs contribute to neuron production in
the adult DG.
Materials andMethods
Animals. Wild-type C57BL/6 mice were purchased from The Jackson
Laboratory (Bar Harbor, ME) or Charles River Laboratories (Wilming-
ton, MA). Tbr2-GFP (green fluorescent protein) mice were obtained
from the GENSAT Project (Gong et al., 2003) and maintained on a CD1
background. The generation of transgenic reporter nestin-GFP mice was
described previously (Mignone et al., 2004). Animals were housed under
standard conditions (12 h light/dark cycle), and all experimental proce-
dures were approved by the University of Washington Institutional An-
imal Care and Use Committee. All animals used were 3–5 months of age,
unless otherwise indicated.
Histology and immunohistochemistry. Animals were deeply anesthe-
tized with Avertin and perfused with cold, buffered 4% paraformalde-
hyde in 0.1 M phosphate buffer. Brains were postfixed for 2 h or overnight
at 4°C and transferred to 30% sucrose overnight at 4°C. For acute bro-
modeoxyuridine (BrdU) labeling, 5-month-old C57BL/6 mice were in-
jected intraperitoneally with BrdU (100 g/g in 0.9% saline; Sigma-
Aldrich, St. Louis, MO) and perfused 2 h postinjection. Tissues were
sectioned coronally at 40 m on a sliding microtome and stored at
20°C in cryoprotectant solution or sectioned sagittally at 12 m on a
cryostat, mounted on Superfrost Plus glass slides (Thermo Fisher Scien-
tific, Waltham, MA), and stored at80°C.
Immunohistochemical analyses were performed as described previ-
ously (Englund et al., 2005). Briefly, sections were boiled in 10 mM so-
dium citrate, pH 6.0, and blocked in 10% normal serum, 0.1% Triton
X-100 (Sigma-Aldrich), and 2% bovine serum albumin (Sigma-Aldrich)
for 1 h at room temperature. Incubation with primary antibodies was
performed at 4°C overnight. Secondary antibodies were applied to sec-
tions for 2 h at room temperature. All primary antibodies used in the
present studies are listed in Table 1. Secondary antibodies were conju-
gates of Alexa Fluor 488, Alexa Fluor 594, and Alexa Fluor 647 (1:200;
Invitrogen, Carlsbad, CA). TO-PRO-3 iodide (0.1 M; Invitrogen) and
DAPI (4,6-diamidino-2-phenylindole) (0.01%; Invitrogen) were used
as nuclear counterstains.
Confocal microscopy and antigen colocalization. To quantitatively ex-
amine colocalization of Tbr2 with antigens of interest, every twentieth 12
m section or every sixth 40m section (six to eight sections per animal
in both cases) through the rostrocaudal extent of the dentate gyrus was
double immunostained. Optical sections (0.4 –1 m) were collected us-
ing a Bio-Rad (Hercules, CA) LS200 confocal microscope with 1.3 nu-
merical aperture (N.A.), 40, or 1.4 N.A, 60 oil objectives through at
least 50 randomly selected cells per animal (n 3 mice), and the pheno-
types of these cells were assessed as described previously (van Praag et al.,
1999; Kronenberg et al., 2003). Three-dimensional reconstructions and
orthogonal views were prepared using Axiovision Inside4D software
(Zeiss, Thornwood, NY). Images were adjusted for contrast, brightness,
and color using Adobe Photoshop CS2 (Adobe Systems, Mountain View,
CA).
BrdU pulse chase experiments. Three-month-old female C57BL/6 mice
were injected with a single pulse of BrdU (100 g/g body weight) and
randomly assigned to different survival time points. Animals were per-
fused at survival time points 2 h, 24 h, 3 d, and 7 d after BrdU adminis-
tration (n 3 animals per time point) as described previously (Kronen-
berg et al., 2003). Brains were sectioned at 40m, and every sixth section
was triple labeled for BrdU, Tbr2, and Sox2. An adjacent one-in-six series
was selected from each brain and triple labeled for BrdU, Tbr2, and
Doublecortin (DCX). The phenotypes of BrdU-positive cells were as-
sessed by collecting confocal z-stacks using a 60 1.4 N.A. oil objective
through all BrdU-labeled cells in the GCL and examining these cells for
coexpression of the other markers listed above. Results are presented as
the fraction of labeled cells to the total number of BrdU-positive cells.
Unidentified cells refer to BrdU-positive cells that did not coexpress
other assessed antigens.
Running experiments. Eight-week-old female C57BL/6 mice were ran-
domly assigned to standard housing [control (CTR), n  4; CTR 14
weeks, n 4] or cages with a running wheel (RUN) as described previ-
ously (van Praag et al., 1999; Kronenberg et al., 2003). Mice in the RUN
group had voluntary access to the wheel for 10 d. BrdU (50 g/g) was
given at the end of the running period, and mice were perfused 1 d (RUN,
n  4) or 4 weeks later (RUN 28 d, n  4). Control mice were age
matched to each running group and were perfused at 10 weeks of age
(CTR) and 14 weeks of age (CTR 14 weeks) for comparison with the
RUN and RUN 28 d groups, respectively. Total cell number counts
(Tbr2 and Tbr2/BrdU) were conducted using an AxioImager.Z1
epifluorescence microscope and Axiovision 4.6 software (Zeiss) with a
modified stereological procedure, where cells were excluded from counts
if they intersected the top focal plane of the section, as described previ-
ously (Williams and Rakic, 1988; van Praag et al., 1999; Kronenberg et al.,
2003). Cells were counted on every sixth 40 m coronal section through
the DG, and the sum of these counts was multiplied by six to generate
estimates of absolute numbers. Statistical analyses of Tbr2 cells were
conducted using ANOVA with Tukey’s honestly significant difference
post hoc test (SPSS, Chicago, IL). Comparisons of Tbr2/BrdU cells
excluded the RUN 28 d group, because no double-labeled cells were
Table 1. Primary antibodies used in the present study
Primary
antibodies Species Dilution Source
BrdU Rat IgG 1:400 Accurate Chemical & Scientific (Westbury, NY)
Calbindin Mouse IgG 1:1000 Sigma-Aldrich (clone CB-955)
Calretinin Mouse IgG 1:1000 Millipore (Billerica, MA) (MAB1568)
Doublecortin Goat IgG 1:250 Santa Cruz Biotechnology (Santa Cruz, CA) (sc-8066)
GFAP Mouse IgG 1:1000 Millipore (MAB360)
GFAP Rabbit IgG 1:1000 Dako Denmark A/S (Glostrup, Denmark)
GFP Mouse IgG 1:500 Millipore (MAB3580)
GFP Rabbit IgG 1:500 Millipore (AB3080)
Mash1 Mouse IgG 1:200 BD Biosciences (San Jose, CA) (clone 24B72D11.1)
NeuN Mouse IgG 1:1500 Millipore (MAB377)
NeuroD Goat IgG 1:400 Santa Cruz Biotechnology (sc-1084)
Ngn2 Mouse IgG 1:2 Dr. D. Anderson (California Institute of Technology, Pasadena, CA)
Pax6 Mouse IgG 1:2000 Developmental Studies Hybridoma Bank (University of Iowa, Iowa City, IA)
PCNA Mouse IgG 1:2000 Millipore (MAB424)
Prox1 Rabbit IgG 1:500 Dr. S. Pleasure (University of California, San Francisco, San Francisco, CA)
PSA-NCAM Mouse IgM 1:800 Millipore (MAB5324)
S100 Mouse IgG 1:1000 Abcam (Cambridge, MA) (ab16959)
Sox2 Goat IgG 1:500 Santa Cruz Biotechnology (sc-17320)
Tbr1 Rabbit IgG 1:2000 R.F.H.
Tbr2 Rabbit IgG 1:2000 R.F.H.
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observed, and used Student’s t test. Significance was achieved at a level of
p 0.05.
Cluster analysis. Cell cluster size was determined in RUN and CTR
mice. Clusters were defined as groups of Tbr2 cells in the SGZ wherein
individual cells were separated by1.5 cell diameters (15m) from their
nearest neighbor. Cells separated by1.5 cell diameters were counted as
separate clusters. Average cell diameter was determined in both groups
by measuring the length of the cells across their longest axis using Axio-
vision 4.6 software (Zeiss). At least 50 randomly selected Tbr2 cells per
animal were measured (n 4 animals/group), and there was no signifi-
cant difference between groups. Clusters were counted in every sixth 40
m coronal section (n  4 animals/group) and compared using Stu-
dent’s t test.
Antimitotic treatment. Three-month-old C57BL/6 mice were given
1.5% Cytosine -D-arabinofuranoside (Sigma-Aldrich) dissolved in
0.9% saline via an osmotic minipump for 7 d (model 1007D; Alzet,
Cupertino, CA) at stereotaxic coordinates described previously (Seri et
al., 2001, 2004). Procarbazine (0.25 mg/ml; Sigma-Tau Pharmaceuticals,
Gaithersburg, MD) was given concurrently in drinking water. Sham-
operated controls (n 3) were implanted with pumps containing 0.9%
saline and given normal drinking water. Intact controls (n  4) were
unoperated age-matched mice. Survival times were 0, 2, 5, 15, and 30 d
after withdrawal of drug treatment (n 4 for all groups, except n 3 for
15 d group). At each time point, mice were given two BrdU injections (50
g/g) 12 h apart, with the last injection given 2 h before perfusion, as
described previously (Seri et al., 2004). Absolute cell numbers were quan-
tified using a modified stereological procedure and statistically analyzed
using ANOVA as described above (Williams and Rakic, 1988; van Praag
et al., 1999; Kronenberg et al., 2003).
Results
Morphology and proliferation of Tbr2 cells
Tbr2 protein expression was restricted to the SGZ of the DG and
was not present in any other regions of the hippocampus (Fig.
1A,C). Tbr2-GFP transgene expression was prominent in the
SGZ and also apparent in some cells in the inner portion of the
GCL (Fig. 1B,C). The number of Tbr2-GFP cells was consis-
tently higher than the number of Tbr2 cells, likely as a result of
GFP perdurance. In both cases, cells expressing Tbr2 were typi-
Figure 1. Tbr2 expression in the adult DG. A, Tbr2 protein was restricted to cells in the SGZ (arrowhead).B, Tbr2-GFP expressionwas strongest in clustered cells in the SGZ (arrowheads) and also
apparent in the inner GCL. C, Merged images showed that the majority of Tbr2-positive cells also expressed Tbr2-GFP (arrowhead); however, Tbr2-GFP expression was more widespread than Tbr2
protein expression.D–F, Cells expressing Tbr2-GFP had diversemorphologies, somewith tangentially oriented cell bodies typical of type-2 cells (D) and somewith processes extending into the GCL
similar to immature neurons (E, F ).G,H, Tbr2 cells proliferated in the SGZ as shown by colabelingwith acute BrdU (G, arrowhead) and PCNA (H, arrowhead). Orthogonal views of double-labeled
nuclei through the x-z and y-z axes of confocal stacks are separated bywhite lines inG–N. I, GFAP-positive processeswere typically observed to surround Tbr2 cells, but the cellular origin of these
processes was difficult to discern (arrowheads). J, K, Tbr2 cells colocalized with some PSA-NCAM and DCX cells, but expression was low in double-labeled cells (J, K, arrowheads), which were
often surrounded byDCX or PSA-NCAM single-labeled cells. L, Tbr2 protein did not colocalizewith calretinin.M,N, Tbr2 protein did not colocalizewith either of themature granule cellmarkers
calbindin or NeuN. Scale bars: (in C) A–C, 100m; (in D) D–F, 15m; G, 15m; H–N, 20m.
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cally found in clusters in the SGZ (Fig. 1A–
C). Tbr2-GFP expression revealed the
morphology of Tbr2 cells, most of which
exhibited short processes tangentially ori-
ented to the GCL (Fig. 1D). In some cases,
Tbr2-GFP cells with morphology sug-
gestive of newly born neurons and long
processes oriented toward the GCL were
observed (Fig. 1D–F).
To examine the proliferation of Tbr2
cells, animals were injected with BrdU
(100 g/g) and killed 2 h postinjection
(Fig. 1G). Counts of Tbr2/BrdU cells
showed that 34.4  5.4% (mean  SEM)
of Tbr2 cells in the SGZ were BrdU,
indicating that a significant proportion
were in S phase. Additionally, Tbr2 cells
accounted for 75.97  5.86% of these
BrdU cells, suggesting that Tbr2 cells
represent a large majority of rapidly divid-
ing cells in the SGZ. As well, 92.6  3.8%
of Tbr2 cells colocalized with proliferat-
ing cell nuclear antigen (PCNA), indicat-
ing that the vast majority of Tbr2 cells
were mitotically active (Fig. 1H). In total,
55.64 3.95% of PCNA cells were cor-
respondingly Tbr2, suggesting that
Tbr2 cells may account for half or more
of the total dividing progenitor population
in the SGZ. (For a summary of the quanti-
tative data from these and related colocal-
ization experiments, see Fig. 4S.)
Characterization of Tbr2 cells in
the SGZ
The phenotype of Tbr2 cells was assessed
by double-labeling immunohistochemis-
try. Neither Tbr2 nor Tbr2-GFP colocal-
ized with the glial marker S100 (Fig.
4
Figure 2. Tbr2-GFP does not colocalize with glial markers,
but short-term lineage tracing reveals colocalization with
neuronal markers. Single-channel images are presented in
gray scale. Orthogonal views are separated by white lines in
each panel. A–C, Tbr2-GFP (arrow) did not clearly colocalize
with GFAP (arrowhead), an astrocytemarker expressed in the
processes but not cell bodies of type-1 progenitors as well as
astrocytes in the GCL. D–F, Tbr2-GFP (arrow) did not colocal-
ize with the glial marker S100 (arrowhead). G–I, Similar to
Tbr2 protein expression, a small proportion of Tbr2-GFP
cells colocalizedwith Sox2, an early IPCmarker (arrowheads).
J–L, Tbr2-GFP colocalized with a significant proportion of
DCX cells (arrowhead). M–O, Similarly, coexpression of
NeuroD, an immature granule neuron marker, was apparent
in many Tbr2-GFP cells (arrowheads). P–R, Many Tbr2-
GFP cells colocalized with calretinin (arrow, arrowhead), a
marker of immature neurons in the DG. S–U, Some Tbr2-
GFP cells colocalized with NeuN, which is expressed in all
neuronal nuclei. Generally, Tbr2-GFP/NeuN cells ex-
pressed GFP more weakly (arrow) than Tbr2-GFP/NeuN
cells (arrowhead), suggesting that Tbr2-GFP expression is
downregulated as postmitotic granule cellsmature. Scale bar,
10m.
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2D–F) (data not shown). Clear colocalization of Tbr2 or Tbr2-
GFP with GFAP, a marker of type-1 progenitors and astrocytes in
the GCL, was difficult to assess because of the abundance and
unclear cellular origin of GFAP processes in the GCL (Figs. 1 I,
2A–C). In some cases, Tbr2 cells were
surrounded by GFAP processes, but it
was impossible to determine whether
these processes originated from the Tbr2
cells themselves or from neighboring
GFAP cells (Fig. 1 I). Therefore, we
turned to nestin-GFP transgenic mice in
which nestin-GFP is expressed in and re-
veals the morphology of subpopulations of
both type-1 and type-2 progenitors (Filip-
pov et al., 2003; Mignone et al., 2004) to
more directly determine which progenitor
populations express Tbr2. In total,
95.09  1.21% of Tbr2 cells colabeled
with nestin-GFP. Tbr2 cells represented
a smaller proportion of nestin-GFP cells,
accounting for only 30.98  0.44% of the
total nestin-GFP population. When the
morphology of cells colabeled with nestin-
GFP and Tbr2 was examined, only 3.24
0.39% of Tbr2 cells were found to ex-
hibit typical type-1 progenitor morphol-
ogy, with a prominent radial process ex-
tending into the GCL (Fig. 3G–I). Tbr2
expression was weak in type-1 progeni-
tors, and these cells appeared to be divid-
ing to produce clusters of nestin-GFP
cells with stronger Tbr2 expression (Fig.
3G–I). Tbr2 cells coexpressing nestin-
GFP were more typically found in clusters
in the SGZ and were often noted to be in
close association with a Tbr2-negative
type-1 nestin-GFP cell (Fig. 3J–L). Of all
the nestin-GFP, Tbr2 double-labeled
cells examined, 96.76  0.39% had mor-
phology consistent with type-2 progeni-
tors, suggesting that Tbr2 expression is
primarily restricted to IPCs.
Consistent with increasing expression
of Tbr2 in the IPC component of SGZ pro-
genitors, colabeling with Sox2, a TF ex-
pressed in many type-1 and type-2 (mainly
type-2a) cells in the SGZ (Kronenberg et
al., 2003; Ferri et al., 2004), showed that
34.5  5.9% of Tbr2 cells were Sox2,
including some double-labeled mitotic
figures (Fig. 4A–C). Tbr2 cells repre-
sented a small proportion of the total
Sox2 population, accounting for only
17.39 3.15% of all Sox2 cells (Fig. 4S).
Pax6, also previously documented in
type-1 and type-2a cells (Maekawa et al.,
2005; Nacher et al., 2005), colocalized with
35.7  1.7% of Tbr2 cells, supporting
expression of Tbr2 in early stage IPCs (Fig.
4D–F). Similar to the results documented
for Sox2, Tbr2 cells accounted for only
17.92  1.07% of total Pax6 cells (Fig.
4S). Additionally, Ngn2, likewise recently
documented in type-2a SGZ progenitors (Ozen et al., 2007), co-
localized with a subset of Tbr2 cells (Fig. 4 J–L).
DCX and polysialylated neural cell adhesion molecule (PSA-
NCAM) were used to determine whether Tbr2 colocalizes with
Figure 3. Sequential expression of TFs in nestin-GFP progenitors. Single-channel images are presented in grayscale. Or-
thogonal views are separatedby thewhite lines in eachpanel.A–C, Pax6was expressed in nestin-GFP cellswith a clearly visible
radial process typical of type-1 cells (arrowhead) and in some adjacent nestin-GFP type-2 cells (arrow). D–F, Mash1 was
expressed in type-1 cells (arrowhead) and in some type-2 nestin-GFP cells (arrow). G–I, Rarely, Tbr2 was weakly expressed in
type-1progenitors(arrowhead)butwasmorestronglyexpressedinadjacentnestin-GFPcellswithtype-2cellmorphology(arrow).J–L,
Nestin-GFP/Tbr2 cells (arrows) were commonly found in clusters next to a Tbr2-negative type-1 cell (arrowhead).M–O, Tbr1 was
expressed in granule cells but did not colocalizewith nestin-GFPprogenitors (arrowhead). Scale bar, 10m.
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markers of progenitors committed to a
neuronal lineage. The majority of Tbr2
cells colabeled with DCX (64.4  4.7%)
(Fig. 4S). In general, these cells had low
DCX expression, with either no processes
or short, tangentially oriented processes,
typical of type-2 cells (Fig. 1K). PSA-
NCAM colabeling was observed in 41.2
4.4% of Tbr2 cells in the SGZ. These cells
exhibited weak PSA-NCAM staining with
small or absent processes similar to the
pattern observed for DCX (Fig. 1 J,K).
Tbr2 cells accounted for relatively small
proportions of the DCX and PSA-NCAM-
positive populations (	33 and 23%, re-
spectively) (Fig. 4S), suggesting that Tbr2
is progressively downregulated as cells be-
come committed to the neuronal lineage
and then exit the mitotic cycle. Consistent
with this idea, Tbr2 did not colocalize with
calretinin, a marker of immature granule
cells (Fig. 1L). Similarly, Tbr2 did not co-
localize with calbindin or NeuN
(neuronal-specific nuclear protein), both
of which are expressed in granule neurons
(Fig. 1M,N).
To conclusively determine whether
Tbr2 cells give rise to a neuronal lineage,
Tbr2-GFP transgenic mice were used (Fig.
1A–C). The overlap between Tbr2 and
Tbr2-GFP was first quantified, and it was
found that although nearly all Tbr2 cells
expressed Tbr2-GFP (92.53 0.33%), only
30.39 2.26% of Tbr2-GFP cells were co-
labeled with Tbr2. These results suggested
4
Figure 4. Tbr2 is part of a TF cascade in the adult SGZ.
Merged images are shown with orthogonal views separated
by white lines in each panel. Single-channel images of
double-labeled cells are shown in grayscale. A–C, Tbr2 colo-
calized with some Sox2 cells in the SGZ, including double-
labeled mitotic figures (arrow). Clusters of Sox2/Tbr2
cells were also apparent (arrowheads). D–F, Pax6/Tbr2
cell clusters were observed in the SGZ, with individual cells
expressing varying levels of each TF (arrowhead). G–I,
Mash1 cells were often clustered with Tbr2 cells, but
strong coexpression occurred in only a small subset of labeled
cells. Rarely,Mash1/Tbr2mitotic figureswere found (ar-
row) near strongly Tbr2 cells that weakly expressed Mash1
(arrowhead). J–L, Clusters of Ngn2/Tbr2 cells (arrows)
adjacent to Tbr2/Ngn2 cells (arrowhead)were observed.
M–O, NeuroD/Tbr2 cells were found frequently in clus-
ters (arrow), but NeuroD expression was more widespread
than Tbr2 expression, and single-labeled cells were common
(arrowhead).P–R, Tbr1was expressed in postmitotic granule
cells, including some Tbr2-GFP cells (arrows). S, Quantifica-
tion of phenotypes of Tbr2-positive cells in the SGZ. Blue bars
represent the fraction of Tbr2/marker cells divided by
total Tbr2 cells. Gray bars represent the fraction of Tbr2/
marker cells divided by totalmarker cells. Eachmarker is
indicated on the x-axis. Error bars represent themean SEM
for each phenotype. T, Schematic diagram of TF expression in
the DG. Scale bars, 20m.
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that Tbr2-GFP expression persisted longer than native Tbr2 protein
expression, thus allowing for short-term lineage tracing to be con-
ducted using Tbr2-GFP with double-labeling immunohistochemis-
try. Colocalization with Sox2 indicated that, similar to Tbr2 expres-
sion, Tbr2-GFP was expressed early in the SGZ progenitor lineage
(Fig. 2G–I). Persistent Tbr2-GFP expression revealed colocalization
with several neuronal lineage markers, including DCX (Fig. 2J–L),
calretinin (Fig. 2P–R), NeuN (Fig. 2S–U), and the granule cell mark-
ers Tbr1 (Fig. 4P–R) and Prox1 (data not shown). Quantification of
Tbr2-GFP coexpression with NeuroD, a marker of newly generated
granule cells (Pleasure et al., 2000; Schwab et al., 2000; Seki, 2002;
Seri et al., 2004), indicated that 88.85 2.62% of Tbr2-GFP cells
coexpressed NeuroD, and that Tbr2-GFPcells accounted for more
than half of the population of NeuroD neuroblasts (58.64 
8.95%). Together, these results strongly suggest that Tbr2 cells
ultimately give rise to new neurons in the adult GCL.
Tbr2 is part of a TF cascade in the SGZ
To examine whether TF cascades active during embryonic neu-
rogenesis are recapitulated in the adult DG, a series of double-
labeling immunohistochemistry experiments was conducted.
Pax6 expression was observed in many nestin-GFP cells exhib-
iting typical type-1 cell morphology. In some cases, these cells
appeared to be dividing to produce Pax6 cells with morphology
typical of type-2 progenitors (Fig. 3A–C). Colabeling with Tbr2
and Pax6 showed clusters of cells with double-labeled Tbr2/
Pax6 cells and single-labeled Pax6 or Tbr2 cells (Fig. 4D–
F), supporting reports that Pax6 expression persists transiently
into early type-2 cells (Maekawa et al., 2005; Nacher et al., 2005).
Tbr2 cells were frequently nestin-GFP and had morphology
consistent with type-2 progenitors (Fig. 3G–L). Nestin-GFP/
Pax6/Tbr2 cells with morphology typical of type-1 and
type-2 cells were also observed (supplemental Fig. 1, available at
www.jneurosci.org as supplemental material). A majority of
Tbr2 cells (65.3 11.4%) colocalized with NeuroD, and these
cells were often apparent in clusters in the SGZ (Fig. 4M–O).
However, NeuroD expression was more widespread in the GCL
with only 24.5 6.7% of NeuroD cells coexpressing Tbr2 (Fig.
4S), confirming that NeuroD expression persists into postmitotic
neuroblasts (Pleasure et al., 2000; Schwab et al., 2000; Seki, 2002; Seri
et al., 2004). Tbr1 expression was observed only in postmitotic gran-
ule cells and was not detected in progenitor cells, because Tbr1 never
colocalized with nestin-GFP (Fig. 3M–O). These results suggest that
sequential expression of Pax63Tbr23Tbr1 occurs during gluta-
matergic neurogenesis in the adult DG (Fig. 4T), as in the developing
neocortex (Englund et al., 2005).
Several other TFs were examined to determine their relation-
ship with Tbr2 cells in the SGZ (Fig. 4S,T). Ngn2 was shown
previously to be expressed by type-1 and type-2a progenitors in
the SGZ (Ozen et al., 2007). We found very few Ngn2 cells in
SGZ, as others have noted (Ozen et al., 2007), making quantita-
tive estimates difficult to determine; however, Ngn2 was ob-
served to colocalize with a subset of Tbr2 cells (Fig. 4 J–L).
Previous studies demonstrated Mash1 expression in clustered
cells in the SGZ, some of which expressed GFAP (Pleasure et al.,
2000; Kim et al., 2007; Seki et al., 2007). Similarly, we found that
Mash1 was expressed in some nestin-GFP type-1 cells and in a
subset of nestin-GFP cells with type-2 cell morphology (Fig.
3D–F). Mash1 cells accounted for a subset of Tbr2 cells
(30.41 2.40%) (Fig. 4S); double-labeled cells included mitotic
figures, indicating overlap of Mash1 and Tbr2 expression within
proliferating progenitors (Fig. 4G–I). Triple labeling with
Mash1, Tbr2, and nestin-GFP showed Mash1 type-1 cells adja-
cent to clusters of nestin-GFP/Tbr2 type-2 cells (supplemen-
tal Fig. 2, available at www.jneurosci.org as supplemental mate-
rial), suggesting that Mash1 expression may precede Tbr2
expression in SGZ progenitors. Consistent with this idea, Tbr2
cells accounted for only 22.68 1.60% of all Mash1 cells in the
SGZ (Fig. 4S). These findings expand the commonality of se-
quential TF expression between developing neocortex and adult
hippocampus, to at least include Pax63Ngn23 Tbr23Neu-
roD 3 Tbr1 (Fig. 4T). Additional TFs, including high-level
Mash1 and Prox1, appear to be attached to this core TF cascade as
part of a DG-specific program that is not activated in embryonic
neocortex. [However, low levels of Mash1 may be expressed in
many embryonic neocortical progenitors (Britz et al., 2006)].
BrdU pulse chase confirms expression of Tbr2 in
type-2 progenitors
The time course of appearance of Tbr2 cells in different pro-
genitor subpopulations was examined using a BrdU pulse chase
time series experiment (Kronenberg et al., 2003). To examine the
expression of Tbr2 in early IPC progenitor stages (type-2a and
type-2b progenitors), colabeling with Sox2 was used (Steiner et
al., 2006). Two hours after administration of BrdU, 90% of
BrdU cells coexpressed either Tbr2 or Sox2, and a majority of
the BrdU cells expressed both of these TFs (58.67  2.64%)
(Fig. 5A). Very few proliferating cells expressed only Tbr2 at this
time point (7.56  1.23%), indicating that rapidly proliferating
population consisted primarily of type-2a and type-2b Sox2/
Tbr2 progenitors. Sox2/BrdU cells accounted for 23.4 
3.1% of the BrdU-labeled cells at this time point, consistent with
the predominance of early IPCs (type-2a cells) 2 h after BrdU
administration (Kronenberg et al., 2003; Steiner et al., 2006). The
proportion of BrdU cells labeled with Tbr2 and not Sox2 cor-
respondingly increased 24 h after BrdU administration (36.35
1.95%), whereas the proportion of BrdU cells expressing only
Sox2 decreased (9.92 0.49%) (Fig. 5A), likely reflecting a shift
toward increased numbers of type-2b and type-3 cells 24 h after
BrdU administration, as described previously (Kronenberg et al.,
2003). At both the 2 and 24 h survival times, very few BrdU cells
were unidentifiable (expressing neither Sox2 nor Tbr2), indicat-
ing that most of the proliferating population at these survival
times consisted of the rapidly dividing type-2 and type-3 cell
populations, supporting previous studies of SGZ progenitor de-
velopment (Kronenberg et al., 2003). Three days after BrdU ad-
ministration, the majority of BrdU cells did not express Tbr2 or
Sox2, reflecting a shift toward later IPC stages (type-3 cells) and
increased production of postmitotic neuroblasts. This trend con-
tinued at the 7 d survival time point, by which time very few
BrdU cells expressed Tbr2 or Sox2 (Fig. 5A).
To examine the progression of Tbr2 cells through later IPC
stages (type-2b and type-3 cells), time series experiments were
performed with BrdU, DCX, and Tbr2 triple labeling. DCX ex-
pression begins in type-2b cells and persists into postmitotic im-
mature neurons (Kronenberg et al., 2003; Kempermann et al.,
2004b). Two hours after BrdU injection, 75% of BrdU cells
were positive for either Tbr2 (57.17  1.1%) or both Tbr2 and
DCX (21.6  0.67%) again reflecting the predominance of
type-2a (Tbr2) and type-2b (Tbr2/DCX) cells at this stage.
Significantly, no Tbr2/DCX/BrdU cells were observed 2 h
after BrdU injection, suggesting that all of the actively dividing
DCXprogenitors at this stage strictly express Tbr2. By 24 h after
BrdU injection, increased numbers of BrdU/DCX/Tbr2
triple-labeled cells were apparent, and the number of BrdU
cells labeled only with Tbr2 (and not DCX) decreased corre-
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spondingly (Fig. 5B), reflecting the shift in the progenitor popu-
lation toward greater numbers of type-2b and type-3 progenitors
at this stage (Kronenberg et al., 2003). This stage also marked the
first appearance of DCX/BrdU cells that did not express Tbr2
(9.05 2.13% of all BrdU cells) (i.e., postmitotic neuroblasts).
By 3 d after BrdU injection, DCX/Tbr2 cells represented the
majority of all BrdU-labeled cells (68.99  3.85%), whereas
BrdU/Tbr2/DCX and BrdU/DCX/Tbr2 cells to-
gether accounted for25% of all BrdU cells (Fig. 5B), indica-
tive of decreased numbers of early stage IPCs by this survival time
(Kronenberg et al., 2003). This trend continued at 7 d after BrdU
administration, by which point BrdU/DCX/Tbr2 cells ac-
counted for 88.56 7.94% of all BrdU cells, and BrdU cells
labeled only with Tbr2 or Tbr2/DCX accounted for10% of the
BrdU-labeled population. These results are consistent with pre-
vious reports demonstrating declining numbers of type-2 and
type-3 at 7 d after BrdU administration, by which time BrdU-
labeled cells have begun to differentiate into postmitotic neuro-
blasts (Kronenberg et al., 2003). Together, these studies suggest
that Tbr2 is predominantly expressed in early IPCs (type-2), with
expression rapidly declining as newly generated cells differentiate
into granule neurons.
Running upregulates Tbr2 cells in the SGZ
The effect of a known neurogenic stimulus on Tbr2 cells in the
SGZ was analyzed in mice allowed 10 d of voluntary access to a
running wheel (RUN mice), which has been shown previously to
increase neurogenesis 1.5-fold to twofold (van Praag et al., 1999;
Kronenberg et al., 2003). Tbr2 cells were markedly stimulated
in RUN mice (3150.5 337.4 cells/DG), increasing by	2.5-fold
compared with CTR mice (1282.5  245.5 cells/DG; F  26.50;
p 0.001) (Fig. 6A–E). The number of Tbr2 cells in RUN 28 d
mice (903  30.3 cells/DG), which were denied running wheel
access for 4 weeks after the initial 10 d period with running wheel
access, was significantly less than RUN mice ( p 0.001) and did
not differ significantly from age-matched controls (CTR 14
weeks, 822  71.7 cells/DG). These results indicate that the in-
crease of Tbr2 cells in RUN mice was transient and directly
related to the neurogenic stimulus (Fig. 6E). The decline in
Tbr2 cells in RUN 28 d mice may also be partially attributable
to an age-related decrease in proliferation (Kronenberg et al.,
2006). Tbr2/BrdU double-labeled cells likewise increased in
RUN mice (1185 130.6 cells/DG), more than doubling relative
to CTR mice (570 76.8 cells/DG; t 4.058; p 0.01), confirm-
ing that the Tbr2 cells in RUN mice were proliferating progen-
itors. Tbr2/BrdU cells were not observed in RUN 28 d mice,
suggesting that surviving BrdU cells differentiated and ceased
to express Tbr2 by this time.
Running increases the size of Tbr2 cell clusters
Small clusters of Tbr2 cells were observed frequently in the SGZ
of both RUN (Fig. 6B,D) and CTR (Fig. 6A,C) mice, but the
clusters seemed to be somewhat larger in RUN mice. To deter-
mine whether running affected cluster size (the number of cells
per cluster), Tbr2 cell clusters were enumerated in both groups.
Mean cluster size was significantly doubled in RUN mice (5.22
0.17 cells) compared with CTR mice (2.46 0.09 cells; t 12.08;
p 0.001). The number of clusters per DG did not differ signif-
icantly between groups (t 2.08; p 0.08); however, there was a
trend toward more clusters per DG in RUN mice (RUN, 146 27
clusters/DG; CTR, 86  10 clusters/DG). In CTR mice, most
Tbr2 cells were present as single cells or pairs of cells. The
frequency of clusters larger than four cells was low in CTR mice,
and clusters larger than eight cells were very rare (Fig. 6F). In
contrast, the frequency of clusters of one to two cells was lower in
RUN mice. Clusters of 4 –10 Tbr2 cells were common, and
large clusters between 12 and 18 cells in size were also observed,
albeit at a low frequency. Rarely, clusters of up to 20 –24 Tbr2
cells were observed, consistent with a notable shift to larger clus-
ter sizes in RUN mice (Fig. 6F).
Antimitotic drug treatment decreases Tbr2 cells in the SGZ
To determine whether Tbr2 cells correspond to the major pop-
ulation of actively dividing neurogenic progenitors (Seri et al.,
2004), mice were treated with antimitotic drugs to ablate rapidly
Figure5. BrdUpulse chase time series experiments. Animalswere collectedat survival times
2 h, 24 h, 3 d, and 7 d after administration of a single pulse of BrdU. A, Triple labeling with
BrdU/Sox2/Tbr2 revealed the time course of appearance of Tbr2 in early stage IPCs (type-2a and
type-2b progenitors). At early time points (2 h, 24 h),most BrdU cells coexpressed Tbr2 (blue
bars), Sox2 (purple bars), or both Tbr2 and Sox2 (green bars). Cells labeled with only BrdU
(unidentified, yellow bars) were rare at 2 and 24 h but increased in proportion at 3 and 7 d after
BrdU administration. Correspondingly, Tbr2, Sox2, and Tbr2/Sox2 labeled cells de-
creased at the 3 and 7 d survival times. B, Triple labeling with BrdU/DCX/Tbr2 showed the time
course of appearance of Tbr2 in later-stage IPCs (type-3 cells). At 2 and 24 h after BrdU admin-
istration,most BrdU cells expressed Tbr2 (blue bars) or both Tbr2 andDCX (red bars). At 3 and
7 d after BrdU injection, the proportions of BrdU/Tbr2 cells and BrdU/DCX/Tbr2
cells declined, and most labeled cells were BrdU/DCX (gray bars), consistent with lineage
progression to postmitotic neurons at later time points. Error bars represent the mean SEM
for each cell type in A and B.
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dividing cells in the SGZ, and Tbr2 and Tbr2/BrdU cells
were then counted at specific intervals after the withdrawal of
drug treatment. Cell counts from sham-operated and unoperated
control animals did not differ significantly and were pooled into
a single control group. ANOVA results for Tbr2 cell counts
revealed highly significant differences between control and anti-
mitotic drug-treated groups (F 35.74; p 0.001) (Fig. 7A). At
0 d posttreatment, Tbr2 cells were reduced to10% of control
values ( p  0.001), indicating a near ablation of Tbr2 cells.
Two days after treatment, the number of Tbr2 cells was 63%
lower than controls ( p  0.001). By 5 d posttreatment, Tbr2
cells returned to control values. However, at 15 d posttreatment,
Tbr2 cells increased to 69% above controls ( p  0.001). This
rebound spike in Tbr2 cells was transient and fell back to con-
trol levels by 30 d posttreatment (Fig. 7A).
Counts of proliferating, Tbr2/BrdU cells followed the
same pattern. ANOVA results again indicated a highly significant
difference between groups (F  16.64; p  0.001) (Fig. 7B).
Tbr2/BrdU cells were nearly absent at 0 d posttreatment,
reaching only 4% of the control value ( p 0.001), and remained
low at 2 d posttreatment (57% of controls; p  0.05). At 5 d
posttreatment, Tbr2/BrdU cells did not differ from controls;
however, a significant increase in Tbr2/BrdU cells above con-
trol levels was observed at 15 d posttreatment ( p  0.005) and
was again followed by a return to control levels at 30 d posttreat-
ment (Fig. 7B). When represented as a percentage of total BrdU
cells, Tbr2/BrdU cells exhibit a similar pattern of increase
from day 0 to control levels at day 5, accounting for only 4.8 
2.1% of BrdU cells at day 0, 21.6 3.9% at day 2, and 41.4
1.4% at day 5 (Fig. 7C). Tbr2/BrdU cells represented 49.6
6.8% of BrdU cells at day 15 and 49.0 2.3% at day 30, both of
which were approximately equivalent to controls (44.6 1.7%).
Discussion
The present study shows that Tbr2, a TF
specifically expressed in IPCs of the em-
bryonic cortex (Englund et al., 2005), is
similarly expressed in type-2 IPCs, with
expression continuing into type-3 IPCs in
the adult DG. Our results show that
Tbr2 cells in the SGZ exhibit morpholo-
gies typical of type-2 and type-3 progeni-
tors and express markers of neuronal lin-
eage restricted progenitors (Kempermann
et al., 2004b; Steiner et al., 2006). Further-
more, studies of nestin-GFP mice revealed
rare expression of Tbr2 in a small number
of type-1 progenitors. Typically, Tbr2
cells formed nestin-GFP clusters in close
proximity to type-1 progenitors. Colocal-
ization with Pax6, Sox2, and Ngn2, all pre-
viously shown to be expressed in type-1
and type-2a progenitors (Kronenberg et
al., 2003; Nacher et al., 2005; Ozen et al.,
2007), suggests that Tbr2 is upregulated
early in the transition between type-1 pro-
genitors and IPCs. Our data demonstrat-
ing the proliferation of Tbr2 cells sup-
ports the morphological identification of
Tbr2 cells as mainly type-2 cells or IPCs.
Previous studies have shown that type-2
cells proliferate rapidly and are readily la-
beled by acutely administered BrdU (Seri
et al., 2001; Filippov et al., 2003; Kronen-
berg et al., 2003; Seri et al., 2004; Steiner et al., 2006). We found
that a significant proportion of Tbr2 cells (34%) are labeled by
a single BrdU pulse, and that90% of Tbr2 cells express PCNA, a
marker of cycling cells. Results from BrdU pulse chase time series
experiments likewise supported the identification of Tbr2 cells as
rapidly cycling IPCs. These experiments suggested that the majority
of proliferating cells 2 and 24 h after BrdU administration express
Tbr2, with Tbr2 expression declining in the BrdU population at
later survival time points (3 and 7 d). These results closely parallel
previous studies showing that most BrdU cells can be identified as
type-2a, type-2b, or type-3 progenitors at 2 and 24 h after BrdU
injection, with these IPC subpopulations declining in favor of post-
mitotic neurons at later survival times (Kronenberg et al., 2003).
Regarding cell fates, our results suggest that Tbr2 progeni-
tors are committed to a neuronal but not glial lineage, because
neither Tbr2-protein nor Tbr2-GFP colocalized with glial mark-
ers. The presence of Tbr2-GFP/Tbr1 cells indicated that
Tbr2 progenitors produce new granule neurons. Our estimates
of total Tbr2 cell number in control animals (	1200 cells)
closely matched previous estimates of the size of the proliferative
population in C57BL/6 mice (	1600 cells) (Hayes and Nowa-
kowski, 2002). Together, our results suggest that Tbr2 is a specific
marker of IPCs and support the use of Tbr2 expression as a mea-
sure of neurogenesis in the adult DG.
Rapidly cycling IPCs have been suggested previously as a tar-
get of neurogenic stimuli, including running (Kronenberg et al.,
2003). Our data from RUN mice clearly show that Tbr2 cells are
upregulated in response to exercise. The increase in Tbr2 cells
shown here correlates well with previous studies showing a 1.5-
fold increase in BrdU cells after running (van Praag et al., 1999;
Kronenberg et al., 2003). Because our data indicate that Tbr2
Figure 6. Running increases Tbr2 cells in the DG. CTR mice (A, C) exhibited visibly lower numbers of Tbr2 cells than RUN
mice (B,D). Large clusters of Tbr2 cells extending into the hilus were apparent in RUNmice (B,D, arrows). E, Total Tbr2 cells
were increased by 2.5-fold in RUNmice (*p 0.001) but returned to control levels (CTR, CTR 14 weeks) 28 d after running (RUN
28d).F, RUNmicehadan increased frequencyof large clusters of Tbr2 cell. In CTRmice,most Tbr2 cellswerepresent as single
cells or doublets. In RUN mice, clusters of more than four cells were common, and very large clusters of20 Tbr2 cells were
documented. Scale bars: A, B, 100m; C, D, 20m. Bar graphs show the mean SEM for each group.
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specifically labels IPCs, the present study supports previous evi-
dence that type-2 cells are regulated by neurogenic stimuli. These
results suggest that Tbr2 may be used as a direct indicator of
neurogenesis without the requirement of extra in vivo labeling
techniques. It should also be noted that not all BrdU cells ex-
pressed Tbr2 in RUN mice. Because astrocyte proliferation is also
increased with running (Steiner et al., 2004), DG progenitors are
presumably heterogeneous with regards to lineage fates. Because
Tbr2 expression was restricted to the neuronal lineage, its use in
future studies as a marker of neurogenesis will provide enhanced
specificity over BrdU alone.
In addition to increased Tbr2 cells, cell cluster size was dou-
bled in RUN mice. Previous reports showed that proliferating
cells form clusters in the SGZ and suggested that clustering facil-
itates intercellular contacts or signals that promote neurogenesis
(Seri et al., 2004; Seki et al., 2007). We observed fewer single
Tbr2 cells in RUN mice, suggesting increased clustering. Al-
though total cluster number did not significantly increase in
RUN mice, the frequency of large cell clusters and the average size
of clusters were clearly increased. These large clusters may result
from increased division of either type-1 progenitors or IPCs.
Given that type-1 cells divide at a slow rate, we speculate that the
increase in mean Tbr2 cluster size results from an increase in
progenitor divisions at the IPC stage, perhaps because of in-
creased probability of cell cycle re-entry. We further propose that
Tbr2 IPCs represent a major regulatory point in adult DG neu-
rogenesis, similar to their suggested role in embryonic neocorti-
cal neurogenesis (Pontious et al., 2008).
The identification of Tbr2 cells as IPCs is further supported
by the results of our antimitotic treatment experiments. Previous
reports have described return of type-2 cells 2–5 d after discon-
tinuing antimitotic treatment (Seri et al., 2001, 2004), essentially
identical to our results. Unexpectedly, we observed a rebound
increase in Tbr2 cells 15 d after treatment, which may represent
an attempt to restore normal neuron numbers after prolonged
ablation. Others have noted increased BrdU cell density after
antimitotic treatment but did not specify the cell types responsi-
ble for this increase (Seri et al., 2001). Importantly, Tbr2 and
Tbr2/BrdU cells exhibited an identical time course of recov-
ery after ablation, strongly supporting a link between Tbr2 ex-
pression and the proliferative response.
Our results suggest that Tbr2 is expressed as part of a TF
cascade that closely resembles embryonic neocortical neurogen-
esis (Englund et al., 2005; Hevner, 2006). In both cases, the se-
quential expression of Pax63Ngn23Tbr23NeuroD3Tbr1
correlates with transition from primary to intermediate progen-
itor stages and ultimately to new glutamatergic neurons. Ngn2,
which is directly regulated by Pax6 during cerebral cortical devel-
opment (Heins et al., 2002; Scardigli et al., 2003) and may in turn
regulate Tbr2 (Schuurmans et al., 2004) was coexpressed in some
Tbr2 cells in adult SGZ. This finding supported our conclusion
that Ngn2 fits into the TF cascade between Pax6 and Tbr2, con-
sistent with a recent report showing that Ngn2 is expressed in
type-1 and type-2a progenitors in the adult DG (Ozen et al.,
2007). Mash1 also appears to be expressed upstream of Tbr2 in
DG progenitors, although the role of Mash1 in cerebral cortex
development is less certain. During development, Ngn1/2 re-
presses Mash1 expression to regulate maturation of cortical pro-
genitor cells (Britz et al., 2006). Others have shown Mash1 ex-
pression in GFAP type-1 cells and some type-2 IPCs in adult
SGZ (Kim et al., 2007; Seki et al., 2007), consistent with our
results. Whereas the TF expression patterns described here are
suggestive of a conserved TF program involved in glutamatergic
neurogenesis, we have not established direct interactions between
individual TFs. Nonetheless, our results strongly suggest that TF
expression cascades, along with environmental stimuli, regulate
neurogenesis in the adult DG.
In summary, we have shown that Tbr2 is a specific marker of
type-2 IPCs in the adult DG. Moreover, Tbr2 IPC numbers
were directly correlated with induced changes in neurogenesis,
suggesting that Tbr2 expression may be a useful measure of adult
DG neurogenesis. As well, these studies show that Tbr2 is ex-
pressed as part of a TF cascade, which likely regulates the transi-
Figure 7. Antimitotic drug treatment decreases Tbr2 cells in the DG. Animals were given
antimitotic drugs for 7 d and examined 0, 2, 5, 15, and 30 d after treatment. A, At 0 and 2 d
posttreatment, Tbr2 cells were significantly reduced compared with control. Tbr2 cells
reached control numbers by 5 d but surpassed controls at 15 d survival. By 30 d survival, Tbr2
cells returned to control values.B, Counts of Tbr2/BrdU progenitor cells showed the same
pattern as Tbr2 cell counts at each survival time point. C, Tbr2/BrdU cells represented a
small fraction of total BrdU cells at 0 d survival and increased thereafter. By 5 d survival,
Tbr2/BrdU cells reached control levels and represented a constant proportion of the total
BrdU cell population at subsequent survival times. Bars represent themean SEM for each
group. *p 0.05, **p 0.005, ***p 0.001.
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tion from proliferating progenitor cells to differentiated glutama-
tergic neurons.
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